Description

7-(2-(2-Aminothiazol-4-Yl)-2-(1-Carboxy-1-Methylethoxyimino)Acetamido)-3-(3-(2,6-Dihydro-7-Hydroxy-6-Oxoisoquinolin-2-Yl)Propen-1-Yl)-3-Cephem-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate belonging to the cephalosporin class of β-lactam antibiotics. This compound is critical for the research and development of next-generation antibacterial agents, offering a sophisticated chemical scaffold for further modification. It is primarily utilized by pharmaceutical manufacturers and research institutions focused on developing novel therapeutics to combat resistant bacterial infections.

Application

• Active Pharmaceutical Ingredient (API) Synthesis: Serves as a key intermediate in the multi-step synthesis of advanced cephalosporin antibiotics.
• Pharmaceutical Research & Development: Used as a critical building block in medicinal chemistry programs aimed at discovering new antibacterial compounds with improved efficacy and spectrum.
• Process Chemistry & Scale-Up: Employed in the development and optimization of commercial-scale manufacturing processes for cephalosporin drugs.
• Reference Standard: Functions as a high-purity analytical standard for quality control and regulatory submissions in pharmaceutical production.
• Antibacterial Mechanism Studies: Utilized in biochemical and microbiological research to study structure-activity relationships (SAR) and bacterial resistance mechanisms.

Basic Information

Product Name	7-(2-(2-Aminothiazol-4-Yl)-2-(1-Carboxy-1-Methylethoxyimino)Acetamido)-3-(3-(2,6-Dihydro-7-Hydroxy-6-Oxoisoquinolin-2-Yl)Propen-1-Yl)-3-Cephem-4-Carboxylic Acid
CAS No.	150256-26-1
Molecular Formula	C30H28N6O9S
Molecular Weight	648.65 g/mol
Synonyms	7-(2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido)-3-(3-(2,6-dihydro-7-hydroxy-6-oxoisoquinolin-2-yl)propen-1-yl)-3-cephem-4-carboxylic acid; Cephalosporin C-30 derivative; (6R,7R)-7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-[(E)-3-(7-hydroxy-6-oxo-1,6-dihydroisoquinolin-2-yl)prop-2-en-1-yl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Advanced Cephalosporin Intermediate; Isoquinolinyl Cephem Derivative
EINECS	Contact for details

Quality Control

Our 7-(2-(2-Aminothiazol-4-Yl)-2-(1-Carboxy-1-Methylethoxyimino)Acetamido)-3-(3-(2,6-Dihydro-7-Hydroxy-6-Oxoisoquinolin-2-Yl)Propen-1-Yl)-3-Cephem-4-Carboxylic Acid is manufactured under strict quality systems. Each batch undergoes rigorous analytical testing to ensure it meets high-purity pharmaceutical-grade standards, with specifications typically aligned with ICH guidelines. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with every shipment to support your regulatory and R&D requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under dry, inert conditions to maintain stability and potency. For long-term storage, consider desiccated environments.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.